- 1446.017
- -0.110-0.01%
Chevron (CVX) Buy Rating Affirmed Amid Strong Q1 Performance and Promising Strategic Initiatives
1 Wall Street Firm Thinks Advanced Micro Devices Stock Is Going to $185 Instead of $200 -- But Is It Still a Buy?
Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and Capital One Financial (COF)
Analysts Offer Insights on Industrial Goods Companies: WW Grainger (GWW), Allegion (ALLE) and Union Pacific (UNP)
Microsoft (MSFT.US) is betting $1.7 billion on Indonesia and Southeast Asia as a new battleground for AI
Microsoft announced that it will invest 1.7 billion US dollars in Indonesia over the next four years to build cloud computing and artificial intelligence infrastructure.
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)
Tesla FSD is about to launch in China, and domestic car companies' smart driving systems are facing major tests
Tesla's intelligent driving system FSD system is gradually getting closer to being implemented in China. On April 29, the text description on the Tesla China FSD purchase page was changed from “coming soon” to “coming soon.” There is also news circulating on the internet that Tesla China is recruiting early FSD experiencers. People familiar with the matter claimed that Tesla and Baidu reached cooperation in the field of maps, which met the requirements of the regulatory authorities. This famous person commented: This will be a historic moment. The impact of Tesla FSD's launch in China is comparable to how it achieved local vehicle production in China in 2020. On April 22, Baidu publicly stated that Tesla will be the first to launch Baidu in May
Express News | Gikyue announced a collaboration with NVIDIA
Microsoft Pledges $1.7B Investment In Emerging Asian Powerhouse As Tech Giants Bet Big On AI
Microsoft Corporation (NASDAQ:MSFT) has committed to a $1.7 billion investment in Indonesia's cloud services and artificial intelligence (AI) over the next four years.What Happened: Microsoft CEO Saty
Coca-Cola, Amazon And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:Wall Street expects The Coca-Cola Company (NYSE:KO) to report quarte
Investor Sentiment Improves Further, Dow Jumps Over 100 Points
The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the "Fear" zone on Monday.U.S. stocks settled higher on Monday, driven by sur
Apple Co-Founder Steve Wozniak Reveals His Unique Obsession With This Weird Object: 'Many Of The Best Things... Aren't Super Functional But They Are Cool'
Steve Wozniak, the co-founder of Apple Inc. on Monday shared his unique fascination with a mathematical object, known as the Klein bottle.What Happened: Wozniak took to X, formerly Twitter, and shared
“He's back”! Musk's net worth skyrocketed by 270 billion yuan after only a 24-hour trip to China
① On Monday, Tesla's stock price recorded its biggest increase in more than three years, and Musk's net worth also achieved the biggest increase in more than two years in the past five days. ② This has caused Wall Street analysts who have looked down on Tesla in recent months to shout: He's back!
Hold Rating on AbbVie Amidst Humira Concerns and Biosimilar Competition Despite Strong Pipeline Prospects
The world's first myocardial myosin inhibitor, mevantul (mavacitai capsules) was approved in China
It is used to treat adult patients with obstructive hypertrophic cardiomyopathy as a myocardial myosin inhibitor. It targets the core pathophysiological mechanism of the disease, reduces excessive myocardial contraction by reducing the formation of excessive myosin and actin crossbridges, and improves relaxation function. Key global and Chinese phase III clinical studies EXPLORER-HCM and EXPLORER-CN show that in Chinese patients with obstructive hypertrophic cardiomyopathy (OHCM) [1], Meavant can significantly improve left ventricular outflow (LVOT) pressure differences at rest or Valsalva stimulation, New York Heart Association (N)
Super Micro Earnings Will Test the Highflying Stock. The Focus Is On AI. -- Barrons.com
By Eric J. Savitz Super Micro Computer remains the year's best-performing technology stock, with a gain of 200% -- and the stock has rallied 700% over the past 12 months. That huge gain reflects Sup
Investors only want to see AI make money; they don't want to listen to AI burn money
The market already requires giants to use AI for revenue.
Amazon AWS, AI, Ads, in Focus for Earnings
Alphabet and Microsoft's strong cloud results sets up a potentially impactful report for Amazon.
TomTom Maps to Support Qualcomm Aware Platform
Qualcomm to utilize TomTom's global map data to assist in providing efficient, secure, and comprehensive asset tracking solutions worldwide.Combining Qualcomm's broad array of connected devices and TomTom's mapmaking
Express News | Genmab and Pfizer say the FDA approved their drug to treat cervical cancer.